PIMREG and cancer: Mechanistically, loss of FASN resulting in ETC inhibition may similarly increase BCL-2/BCL-XL dependency, thereby lowering the threshold for inducing apoptosis, making cancer cells easier to target for cytotoxic signals from CATs, and accelerating CAT-mediated killing.